Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideTMOThermo Fisher Scientific
FinDog View：Bullish
| Metric | STE | TMO |
|---|
| Close | 209.90 | 648.43 |
| Market Cap | $20.5B | $240B |
| 1M | −8.64% | +10.75% |
| P/E (TTM) | 25.5 | 34.4 |
| Forward P/E | 20.4 | 21.8 |
| P/E 5-Yr Percentile | 0 | 65 |
| P/S | 3.4 | 5.2 |
| P/B | 2.8 | 4.6 |
| Dividend Yield | 1.02% | 0.29% |
| Latest Quarter Revenue | $1.5B | $12.0B |
| Revenue YoY | +7.3% | +10.5% |
| Gross Margin | 45.8% | — |
| Latest Quarter EPS | — | 4.68 |
| Avg Post-Earnings Move | ±5.8% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.87% | 2.36% |
| 90-Day Net Insider Buying | −$0.96M | −$38.9M |
STE · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
